Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
MARSHALL WACE LLP | 08-14-2024 | 06-30-2024 | 3628 | 74,893,943,772 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
B/R US EQY FCTR | ETP | 1501 | $9,112,039 | 194,121 | 0.00 | 194,121 | +Inf | 06-30-2024 | |
ACCENTURE PLC-A | EQUITY OPTION | 1502 | $9,102,300 | 30,000 | 0.00 | 30,000 | +Inf | 06-30-2024 | |
AMPHASTAR PHARMA | COMMON STOCK | 1503 | $9,085,080 | 227,127 | 0.00 | 227,127 | +Inf | 06-30-2024 | |
COMSTOCK RES INC | COMMON STOCK | 1504 | $9,071,268 | 873,918 | 0.00 | 0.00 | 716,457 | 455.01 | 06-30-2024 |